SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-011834
Filing Date
2018-08-14
Accepted
2018-08-14 16:34:45
Documents
60
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1082599
2 ex31-1.htm EX-31.1 11530
3 ex31-2.htm EX-31.2 11531
4 ex32-1.htm EX-32.1 4958
5 ex32-2.htm EX-32.2 4972
  Complete submission text file 0001493152-18-011834.txt   4286098

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE aker-20180630.xml EX-101.INS 650081
7 XBRL SCHEMA FILE aker-20180630.xsd EX-101.SCH 59551
8 XBRL CALCULATION FILE aker-20180630_cal.xml EX-101.CAL 55798
9 XBRL DEFINITION FILE aker-20180630_def.xml EX-101.DEF 171512
10 XBRL LABEL FILE aker-20180630_lab.xml EX-101.LAB 399294
11 XBRL PRESENTATION FILE aker-20180630_pre.xml EX-101.PRE 262990
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36268 | Film No.: 181018187
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1